中国麻风皮肤病杂志
中國痳風皮膚病雜誌
중국마풍피부병잡지
CHINA JOURNAL OF LEPROSY AND SKIN DISEASES
2015年
4期
229-231
,共3页
宋淑红%赵栋桉%周静芳%张维娜%朱翊
宋淑紅%趙棟桉%週靜芳%張維娜%硃翊
송숙홍%조동안%주정방%장유나%주익
消瘾方加减%依巴斯汀%慢性荨麻疹
消癮方加減%依巴斯汀%慢性蕁痳疹
소은방가감%의파사정%만성담마진
Xiao-yin decoction%ebastine%chronic urticaria
目的::评价消瘾方加减联合依巴斯汀治疗慢性荨麻疹的临床疗效及对患者IgE、IL-4和IFN-γ水平的影响。方法:133例慢性荨麻疹患者随机分为中西医结合组(52例),中医组(38例)和西医组(43例)。中西医结合组口服消瘾方加减和依巴斯汀片10 mg/d治疗,治疗30天;中医组给予消瘾方加减治疗;西医组口服依巴斯汀片。根据患者瘙痒程度、风团大小、风团数目等评价疗效,ELISA检测3组患者IgE、IL-4及IFN-γ水平变化。结果:治疗第30天中西医结合组、中医组、西医组有效率分别为94.23%、71.05%和74.42%。随访6个月,中西医结合组、中医组、西医组复发率分别为18.37%、33.33%和53.13%。治疗后中西医结合组IgE和IL-4水平降低、IFN-γ水平升高较其它两组更为明显,具有统计学意义(均P<0.05)。结论:消瘾方加减联合依巴斯汀治疗慢性荨麻疹临床疗效好、复发率低,IgE、IL-4和IFN-γ水平变化对临床疗效及复发率的判断有一定的意义。
目的::評價消癮方加減聯閤依巴斯汀治療慢性蕁痳疹的臨床療效及對患者IgE、IL-4和IFN-γ水平的影響。方法:133例慢性蕁痳疹患者隨機分為中西醫結閤組(52例),中醫組(38例)和西醫組(43例)。中西醫結閤組口服消癮方加減和依巴斯汀片10 mg/d治療,治療30天;中醫組給予消癮方加減治療;西醫組口服依巴斯汀片。根據患者瘙癢程度、風糰大小、風糰數目等評價療效,ELISA檢測3組患者IgE、IL-4及IFN-γ水平變化。結果:治療第30天中西醫結閤組、中醫組、西醫組有效率分彆為94.23%、71.05%和74.42%。隨訪6箇月,中西醫結閤組、中醫組、西醫組複髮率分彆為18.37%、33.33%和53.13%。治療後中西醫結閤組IgE和IL-4水平降低、IFN-γ水平升高較其它兩組更為明顯,具有統計學意義(均P<0.05)。結論:消癮方加減聯閤依巴斯汀治療慢性蕁痳疹臨床療效好、複髮率低,IgE、IL-4和IFN-γ水平變化對臨床療效及複髮率的判斷有一定的意義。
목적::평개소은방가감연합의파사정치료만성담마진적림상료효급대환자IgE、IL-4화IFN-γ수평적영향。방법:133례만성담마진환자수궤분위중서의결합조(52례),중의조(38례)화서의조(43례)。중서의결합조구복소은방가감화의파사정편10 mg/d치료,치료30천;중의조급여소은방가감치료;서의조구복의파사정편。근거환자소양정도、풍단대소、풍단수목등평개료효,ELISA검측3조환자IgE、IL-4급IFN-γ수평변화。결과:치료제30천중서의결합조、중의조、서의조유효솔분별위94.23%、71.05%화74.42%。수방6개월,중서의결합조、중의조、서의조복발솔분별위18.37%、33.33%화53.13%。치료후중서의결합조IgE화IL-4수평강저、IFN-γ수평승고교기타량조경위명현,구유통계학의의(균P<0.05)。결론:소은방가감연합의파사정치료만성담마진림상료효호、복발솔저,IgE、IL-4화IFN-γ수평변화대림상료효급복발솔적판단유일정적의의。
Objective: To assess the efficacy of Xiao-yin decoction combined with ebastine in the treat-ment of chronic urticaria ( CU) , and of the influence on the levels of IgE, IL-4 and IFN-γ. Methods:One hundred and thirty-three patients were randomly divided into Xiao-yin decoction combined with ebstine group (52 patients), Xiao-yin decoction group (38 patients) and ebastine group (43 patients). The efficacy was assessed according to the itching degree, numbers and sizes of wheals. The levels of IgE, IL-4 and IFN-γwere detected by ELSA. Results:The effective rates in the Xiao-yin decoction combined with ebstine group, Xiao-yin decoction group and ebastine group were 94.23%, 71.05% and 74.42% after 30 days of the treat-ment, respectively. The recurrence rates in the Xiao-yin decoction combined with ebstine group, Xiao-yin de-coction group and ebastine group were 18.37%, 33.33% and 53.13% after 6 months follow-up. The reduction in the levels of IgE and IL-4 and the increase in the level of IFN-γin the Xiao-yin decoction combined with ebstine group were more obvious than that in the other two groups, with significant differences (P<0.05). Conclusion: Xiao-yin decoction combined with ebastine in the treatment of CU is effective in the treatment of CU. The change in the levels of IgE, IL-4 and IFN- γ are helpful for estimating the prognosis.